Full article view 2017-09-21T12:08:00+00:00
Back to News & Insights »

ISPOR 21st Annual International Meeting

Date: May 21, 2016 – May 25, 2016

ISPOR Annual International Meeting

Precision will be exhibiting in booth 81/82

Location: Washington, D.C.

Precision To Have Strong Presence at ISPOR’s 21st Annual International Meeting, Washington DC

Precision Health Economics (PHE) researchers and scientific advisors will once again have a very strong presence at ISPOR’s 21st Annual International Meeting in Washington DC from May 21-25, 2016. PHE experts will be teaching 2 short courses, moderating and speaking at 3 issue panels, presenting 13 posters, and participating in the National Pharmaceutical Council (NPC) sponsored educational symposium.

In addition, PHE and Precision for Value experts will be located at booths 81-82 throughout the conference. If you are interested in scheduling a time to meet with a member of the PHE team, please email SVP of Business Development, Mark Gianforcaro at mark.gianforcaro@precisionhealtheconomics.com to set a time to meet.

Key sessions featuring PHE experts include:

  • Educational Symposium – “Budget impacts analysis: An acceptable part of value assessments or a discordant concept?”, featuring PHE’s Dr. Darius Lakdawalla. Sunday May 22 from 5:15pm to 6:15pm in the Intl Ballroom East (Concourse Level).
  • Issue Panels Session II – IP7 “Pharmaceutical pricing in the United States: Are we balancing innovation and affordability?”, featuring PHE’s Dr. Dana Goldman and Dr. Tomas Philipson. Tuesday, May 24, 2016 from 11:00am to 12:00pm in the Intl Ballroom West (Entrance-Terrace Level).
  • Issue Panels Session II – IP9 “Next generation comparative effectiveness research – are we getting organized to facilitate research for the individual patient?”, featuring PHE’s Dr. Kristian Thorlund and Dr. Anupam Jena. Tuesday, May 24, 2016 from 11:00am to 12:00pm in the Jefferson Room (Concourse Level).
  • Issue Panels Session III – IP14 “The value of specialty drugs: Can we develop novel access policies for novel medicines?”, featuring PHE’s Dr. Tomas Philipson, Dr. Darius Lakdawalla, Dr. Wade Aubry, and Dr. Anupam Jena. Tuesday May 24, 2016 from 2:15pm to 3:15pm in the Intl Ballroom East (Concourse Level).

PHE’s full offerings during the ISPOR 21st Annual International Meeting:

Saturday

Pre-Meeting Short Course – Outcomes Research Methods Track

Saturday, May 21, 2016 | 1:00pm to 5:00pm | Washington Hilton

“Meta-analysis and systematic reviews in comparative effectiveness research”

Course faculty includes PHE’s Dr. Jeroen Jansen, PhD, MSc

Sunday

Pre-Meeting Short Course – Outcomes Research Methods Track

Sunday, May 22, 2016 | 1:00pm to 5:00pm | Washington Hilton

“Network meta-analysis”

Course faculty includes PHE’s Dr. Jeroen Jansen, PhD, MSc

Educational Symposium – Sponsored by National Pharmaceutical Council (NPC)

Sunday May 22. 2016 | 5:15pm to 6:15pm in the Intl Ballroom East (Concourse Level).

“Budget impacts analysis: An acceptable part of value assessments or a discordant concept?”

Symposium features PHE’s Dr. Darius Lakdawalla, PhD

Monday

➢ Poster Presentations Session I – PHS12, A12

“Emergency department visits associated with ankle sprains in the United States”

PHE Authors: Joshua Noone, Chris Blanchette

➢ Poster Presentations Session I – PHS116, D24

“Evaluation of asthma outcomes in older and younger adults”

PHE Authors: Chris Blanchette

➢ Poster Presentations Session I – PCV80, J4

“A graphical and analytics approach to understanding hospital readmissions in North Carolina”

PHE Authors: Chris Blanchette

➢ Poster Presentations Session I – PCV81, J5

“Estimating the future burden of cardiovascular disease in China and the potential value of universal lipid and blood pressure”

PHE Authors: Warren Stevens, Desi Peneva, Darius Lakdawalla

➢ Poster Presentations Session II – PRS7, H18

“Examining corticosteroid-induced type-2 diabetes in the COPD Medicare population”

PHE Authors: Chris Blanchette

Tuesday

Issue Panels Session II: Health Policy Development Using Outcomes Research Issues – IP7

Tuesday, May 24, 2016 | 11:00am to 12:00pm | Room: Intl Ballroom West (Entrance-Terrace Level) | Washington Hilton

“Pharmaceutical pricing in the United States: Are we balancing innovation and affordability?”

Panel features PHE’s Dr. Dana P. Goldman, PhD, and Dr. Tomas Philipson, PhD

Issue Panels Session II: Clinical Outcomes Research Issues – IP9

Tuesday, May 24, 2016 | 11:00am to 12:00pm | Room: Jefferson (Concourse Level) | Washington Hilton

“Next generation comparative effectiveness research – are we getting organized to facilitate research for the individual patient?”

Panel features PHE’s Dr. Kristian Thorlund, PhD, and Dr. Anupam Jena, MD, PhD

Issue Panels Session III: Health Policy Development Using Outcomes Research Issues – IP14

Tuesday, May 24, 2016 | 2:15pm to 3:15pm | Room: Intl Ballroom East (Concourse Level) | Washington Hilton

“The value of specialty drugs: Can we develop novel access policies for novel medicines?”

Panel features PHE’s Dr. Tomas Philipson, PhD, Dr. Anupam B. Jena, MD, PhD, Dr. Darius Lakdawalla, PhD, and Dr. Wade Aubry, MD.

Wednesday

➢ Poster Presentations Session III – PCN34, B3

“Indirect treatment comparison for cabazitaxel for patients with metastatic castration-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen”

PHE Authors: Nick Summers, Jacqueline Vanderpuye-Orgle

➢ Poster Presentations Session III – PCN190, G2

“The social value of immunotherapy in non-small cell lung cancer”

PHE Authors: Jeff Sullivan, Alison Sexton Ward, Desi Peneva, Jennifer Benner, Darius Lakdawalla, Anupam Jena

➢ Poster Presentations Session IV – PSY27

“Incremental health care cost prior to and post first diagnosis of myasthenia gravis in the commercially insured sample”

PHE Authors: Emily Zacherle, Joshua Noone, Chris Blanchette

➢ Poster Presentations Session IV – PSY28, K13

“Hospitalizations for older patients with acute myeloid leukemia (AML): Inpatient treatment is intensive and costly”

PHE Authors: Naomi Sacks, Joshua Noone, Phil Cyr

➢ Poster Presentations Session IV – PSY32, K17

“Burden of autosomal dominant polycystic kidney disease in US Medicare beneficiaries”

PHE Authors: Joshua Noone, Emily Zacherle, Chris Blanchette

➢ Poster Presentations Session IV – PDB80, C16

“Are financial incentives in pay-for-performance programs sufficient? A case study of diabetes care in Medicare Advantage Plans”

PHE Authors: Kata Bognar, Jason Shafrin

➢ Poster Presentations Session V – PHP86, C20

“Estimating the lifetime price of pharmaceuticals: what are the long-term costs to society?”

PHE Authors: Joanna MacEwan, Darius Lakdawalla

➢ Poster Presentations Session V – PHP96, D1

“Patient characteristics, health outcomes, and predictors of organ failure or rejection of organ transplant recipients in the United States”

PHE Authors: Emily Zacherle, Joshua Noone, Chris Blanchette

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.